alpha-En Corp 8-K, filed Jan 8, 2021
alpha-En Corp (ALPE)
About this 8-K
alpha-En Corp filed this 8-K on January 8, 2021, reporting on events of January 7, 2021.
Items reported
- Item 5.02: Director or officer change, or executive pay
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 7, 2021
Alpha-En Corporation
(Exact name of registrant as specified in its charter)
| Delaware | 001-12885 | 954622429 | ||
|---|---|---|---|---|
| (State<br>or Other Jurisdiction | (Commission | (I.R.S.<br>Employer | ||
| of<br>Incorporation) | File<br>Number) | Identification<br>No.) |
28 Wells Ave, 2^nd^ Floor, Yonkers NY 10701
(Address of Principal Executive Offices) (Zip Code)
(914)418-2000
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| [ ] | Written<br>communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|---|---|
| [ ] | Soliciting<br>material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| --- | --- |
| [ ] | Pre-commencement<br>communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| --- | --- |
| [ ] | Pre-commencement<br>communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| --- | --- |
Securities registered pursuant to Section 12(b) of the Act:
| Title<br>of each class | Trading<br>Symbol(s) | Name<br>of each exchange on which registered | |
|---|---|---|---|
| Common<br>Stock, par value 0.01 per share | ALPE | OTC |
All values are in US Dollars.
| Item<br>5.02 | Departure of Directors or Certain Officers; Election<br>of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
|---|
The Board of Directors of alpha-Encorp on 1/6/2021 unanimously approved the nomination of Gary Goldman, MD to the Board of Directors. Dr. Goldman is a long term significant investor in the company through his family office and he brings a wealth of scientific knowledge and decades of investment experience to the company.
| Alpha-En<br>Corporation | ||
|---|---|---|
| By | /s/<br>Sam Pitroda | |
| Name: | Sam<br>Pitroda | |
| Title: | Chairman<br>and CEO |
Date: 1/7/2021
INDEX TO EXHIBITS
| Exhibit<br>No. | Description | |
|---|---|---|